BELLEROPHON THERAPEUTICS INC's ticker is BLPH and the CUSIP is 078771300. A total of 19 filers reported holding BELLEROPHON THERAPEUTICS INC in Q1 2023. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $485 | -42.4% | 1,221 | 0.0% | 0.00% | – |
| Q2 2023 | $842 | -91.3% | 1,221 | 0.0% | 0.00% | – |
| Q1 2023 | $9,634 | +776.6% | 1,221 | 0.0% | 0.00% | – |
| Q4 2022 | $1,099 | +9.9% | 1,221 | 0.0% | 0.00% | – |
| Q3 2022 | $1,000 | -50.0% | 1,221 | 0.0% | 0.00% | – |
| Q2 2022 | $2,000 | -33.3% | 1,221 | 0.0% | 0.00% | – |
| Q1 2022 | $3,000 | -25.0% | 1,221 | 0.0% | 0.00% | – |
| Q4 2021 | $4,000 | -20.0% | 1,221 | 0.0% | 0.00% | – |
| Q3 2021 | $5,000 | -16.7% | 1,221 | 0.0% | 0.00% | – |
| Q2 2021 | $6,000 | 0.0% | 1,221 | 0.0% | 0.00% | – |
| Q1 2021 | $6,000 | -25.0% | 1,221 | 0.0% | 0.00% | – |
| Q4 2020 | $8,000 | -33.3% | 1,221 | 0.0% | 0.00% | – |
| Q3 2020 | $12,000 | -20.0% | 1,221 | 0.0% | 0.00% | – |
| Q2 2020 | $15,000 | +15.4% | 1,221 | 0.0% | 0.00% | – |
| Q1 2020 | $13,000 | – | 1,221 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| PFS Partners, LLC | 6,000 | $2,386 | 0.00% |
| ACADIAN ASSET MANAGEMENT LLC | 383,178 | $152 | 0.00% |
| TWO SIGMA INVESTMENTS, LP | 113,911 | $45,291 | 0.00% |
| OSAIC HOLDINGS, INC. | 557 | $221 | 0.00% |
| US BANCORP \DE\ | 1,221 | $485 | 0.00% |
| WELLS FARGO & COMPANY/MN | 180,066 | $71,594 | 0.00% |
| NORTHERN TRUST CORP | 30,251 | $12,028 | 0.00% |
| CONCOURSE FINANCIAL GROUP SECURITIES, INC. | 0 | $0 | 0.00% |
| GROUP ONE TRADING, L.P. | 2,100 | $840 | 0.00% |
| GEODE CAPITAL MANAGEMENT, LLC | 95,656 | $38,262 | 0.00% |